Results 201 to 210 of about 26,425 (258)

Characterization and immunogenicity of nanoparticle vaccines displaying embecovirus spike proteins. [PDF]

open access: yesBiotechnol Prog
Halfmann PJ   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Production and purification of hybrid Ty-VLPs

Molecular Biotechnology, 1994
This article describes how pure Ty-VLPs (virus-like particles) can be prepared from hybrid Ty-VLPs. Many different hybrid Ty-VLPs have been produced and may be easily purified. Since the sedimentation properties of different hybrid Ty-VLPs are similar, a simple purification process can be used for any VLP.
N R, Burns   +4 more
openaire   +3 more sources

Influence of MAI in a CDMA VLP system

2015 International Conference on Indoor Positioning and Indoor Navigation (IPIN), 2015
In this paper, we study a Visible Light Positioning (VLP) system using Code Division Multiple Access (CDMA). In order to facilitate implementation, the LEDs are transmitting data in a non-synchronized way to the receiver requiring no backbone network. The positioning algorithm uses the received optical power calculated from the auto- correlation peak ...
Steven De Lausnay   +4 more
openaire   +2 more sources

VLP: a visual logic programming language

Journal of Visual Languages & Computing, 1991
In this paper, we argue that visual programming can be greatly enhanced by integrating some cognitive aspects when designing a visual language. We try to apply some interesting rules-established by Bertin on experimental evidence-to get graphical views which have a good picture quality and hence do not have to be read in a linear way. We introduce VLP,
Didier Ladret, Michel Rueher
openaire   +1 more source

Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease

Antiviral Research, 2016
Foot and mouth disease (FMD) is a highly contagious viral disease of cloven-hoofed animals. Previously, we found that the epitope peptide EP141-160 displayed on virus-like particles (VLP) for use as a vaccine showed high immunoreactivity and conferred partially effective protection to animals.
Yan-mei Dong   +3 more
openaire   +2 more sources

p24-VLP

Drugs of the Future, 1993
S. Adams, G. Patou
openaire   +1 more source

Allergen VLPs

Journal of Allergy and Clinical Immunology, 2017
Louis Philippe Vezina   +2 more
openaire   +1 more source

Assessing the Efficacy of VLP-Based Vaccine Against Epstein-Barr Virus Using a Rabbit Model

Vaccines, 2023
Gulfaraz Khan   +2 more
exaly  

Home - About - Disclaimer - Privacy